Trial intelligence / Profile preview

6 weeks versus 6 months of clopidogrel after drug-eluting stent implantation in warfarin-treated patients

2011-000583-96Phase 4Completed

Sponsor
Aarhus University Hospital
Start
Apr 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of clopidogrel in coronary arteriosclerosis (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Ischemic complications. Started Apr 2011; status: completed.

02

Drugs

clopidogrel
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2011-000583-96.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000583-96.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call